Efficacy of lipid reduction with DALI and MONET-Reference-Cited by-同舟云学术

Efficacy of lipid reduction with DALI and MONET

Published:2017-11 Issue: Volume:30 Page:217-224
ISSN:1567-5688
Container-title:Atherosclerosis Supplements
language:en
Short-container-title:Atherosclerosis Supplements

Author:

Ramlow Wolfgang,Röseler Eberhard,Heigl Franz,Spitthöver Ralf,Ringel Jens,Schmitz Gerd,Heinzler Rainer,Abdul-Rahman Nadim,Leistikow Frank,Himmelsbach Frido,Schettler Volker,Pham Jenny,Kozik-Jaromin Justyna

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Internal Medicine

Reference16 articles.

1. ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European atherosclerosis Society (EAS);Reiner;Eur Heart J,2011

2. Lipoprotein(a) as a cardiovascular risk factor: current status;Nordestgaard;Eur Heart J,2010

3. Indications for apheresis as an ultima ratio treatment of refractory hyperlipidemias;Grutzmacher;Clin Res Cardiol Suppl,2015

4. Lipid apheresis techniques: current status in Germany;Grutzmacher;Clin Res Cardiol Suppl,2012

5. Adverse events of lipoprotein apheresis and immunoadsorption at the apheresis center at the University Hospital Dresden;Dittrich-Riediger;Atheroscler Suppl,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 IgG spike protein antibody response in mRNA-1273 Moderna® vaccinated patients on maintenance immunoapheresis – a cohort study;Frontiers in Immunology;2022-09-26

2. Lipoproteinapherese;Herz;2022-04-22

3. Comparison of plasma separation using centrifugation or filtration for MONET lipoprotein apheresis in patients with cardiovascular disease and severe dyslipidemia;Therapeutic Apheresis and Dialysis;2022-04-06

4. Therapeutic Apheresis for Management of Lp(a) Hyperlipoproteinemia;Current Atherosclerosis Reports;2020-09-18

5. Long-term lipoprotein apheresis in the treatment of severe familial hypercholesterolemia refractory to high intensity statin therapy: Three year experience at a lipoprotein apheresis centre;Cardiology Journal;2020-01-22